From 9 Takeaways from Boston’s Life Science Disruptors:

Disruptors, Exter and Leschly

Disruptors, Exter and Leschly—

Neil Exter and Nick Leschly discussing the history of Bluebird Bio.

Underwriters and Partners

Xconomy Insight

Sponsored · Video
The Bay Area and Beyond: Biocom Talks Innovation and COVID
A Fireside Chat with Biocom President & CEO Joe Panetta
Biocom

Sponsored · Special Report
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future
Hyperinflation in rents is over
Hughes Marino

From Our Editors · Special Report
Xcelerating Life Sciences San Francisco: Special Report
The AI, Big Data, and R&D Boom

Xconomy on Demand

We offer a number of ways to subscribe for free!